AllSight
Companies · LH · Services-Medical Laboratories

LABCORP HOLDINGS INC. (LH)

LABCORP HOLDINGS INC. (LH) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

LABCORP HOLDINGS INC. (LH) stock — financials & valuation

Key numbers for LABCORP HOLDINGS INC. (LH): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 47/100 — a percentile rank of LABCORP HOLDINGS INC.’s fundamentals against Services peers, weakest on profitability. A quality ranking, not a price prediction.

Market cap$24.7B
P / E24.6×
P / S1.7×
EV / EBITDA13.1×
Gross margin28.9%
Operating margin10.4%
Net margin7.0%
Return on equity11.7%
ROIC8.5%
Revenue growth6.4%
Debt / equity0.7×
Dividend yield1.0%

Is LABCORP HOLDINGS INC. overvalued? P/E looks fair vs its 5-year range; P/S looks overvalued vs its 5-year range; EV/EBITDA looks fair vs its 5-year range; P/B looks overvalued vs its 5-year range.

Independent of the events above — derived from LABCORP HOLDINGS INC.’s own financial statements and shown as context, never as advice.

Sep 22, 2026Guidance reaffirmed
Labcorp reaffirms 2026–29 outlook despite looming Medicare lab cuts
Sep 10, 2026Guidance reaffirmed
Labcorp reaffirms 2026 guidance, but 2029 targets offer few fresh surprises
Aug 28, 2026No new info
Labcorp schedules healthcare conference fireside chat with no new business disclosure
Aug 17, 2026No new info
Labcorp schedules its next big test: strategy, capital allocation, and long-term targets
Aug 14, 2026Leadership transition
Labcorp loses a lab chief—but avoids a wholesale leadership reset
Related companies in Services-Medical Laboratories
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact